Pagona Flevari

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.

COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.

Journal: Orphanet journal of rare diseases

Published: January 04, 2025

Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.

Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.

Journal: HemaSphere

Published: July 25, 2024

Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.

Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.

Journal: International journal of molecular sciences

Published: March 29, 2024

Peripheral Neuropathy in Patients with Hepatitis C Infection-Reversibility after HCV Eradication: A Single Center Study.

Peripheral Neuropathy in Patients with Hepatitis C Infection-Reversibility after HCV Eradication: A Single Center Study.

Journal: Viruses

Published: January 30, 2024

High-Oxygen-Affinity Hemoglobins-Case Series and Review of the Literature.

High-Oxygen-Affinity Hemoglobins-Case Series and Review of the Literature.

Journal: Journal of clinical medicine

Published: December 02, 2023

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?

Journal: Diseases (Basel, Switzerland)

Published: October 07, 2023

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

Journal: European journal of clinical pharmacology

Published: July 01, 2023

Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review.

Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review.

Journal: Biomedicines

Published: November 03, 2022

Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.

Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.

Journal: The American journal of case reports

Published: October 16, 2021

Outcomes of pregnancies in patients with Gaucher Disease: The experience of a center of excellence on rare metabolic Disease-Gaucher Disease, in Greece.

Outcomes of pregnancies in patients with Gaucher Disease: The experience of a center of excellence on rare metabolic Disease-Gaucher Disease, in Greece.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: April 29, 2020

The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/βthal), correlate with markers of hemolysis, iron burden, coagulation, endothelial dysfunction and pulmonary hypertension.

The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/βthal), correlate with markers of hemolysis, iron burden, coagulation, endothelial dysfunction and pulmonary hypertension.

Journal: Blood cells, molecules & diseases

Published: February 25, 2019

Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Journal: Scientific reports

Published: September 27, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026